HYDIA

Source: Wikipedia, the free encyclopedia.
HYDIA
Identifiers
  • (1S,2R,3R,5R,6S)-2-amino-3-hydroxybicyclo[3.1.0]hexane-2,6-dicarboxylic acid
JSmol)
  • C1[C@H]2[C@@H]([C@H]2[C@@]([C@@H]1O)(C(=O)O)N)C(=O)O
  • InChI=1S/C8H11NO5/c9-8(7(13)14)3(10)1-2-4(5(2)8)6(11)12/h2-5,10H,1,9H2,(H,11,12)(H,13,14)/t2-,3+,4-,5-,8-/m0/s1 ☒N
  • Key:NTPXNEQCDPWJQA-AZDHXYLBSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

HYDIA is a drug that is used in neuroscience research, which acts as a potent and selective antagonist for the group II metabotropic glutamate receptors (

competitive antagonist. Other derivatives such as the 3-benzyloxy ether are more potent antagonists than HYDIA itself.[2]

References


This page is based on the copyrighted Wikipedia article: HYDIA. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy